Violation Tracker Individual Record

Company: 
Johnson & Johnson
Current Parent Company: 
Johnson & Johnson
Penalty: 
$541,000,000
Year: 
2013
Date: 
November 4, 2013
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
kickbacks and bribery
Violation Description: 

Johnson & Johnson and its subsidiaries agreed to pay $541 million to resolve multistate litigation alleging unlawful marketing practices, including off-label promotion and kickbacks, to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. The off-label marketing accounted for $524 million; the other $17 million resolved allegations that J&J subsidiary Janssen paid kickbacks to nuring home pharmacy Omnicare. All of this was part of a larger $2.2 billion civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-johnson-an...

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
USA
HQ State of Parent: 
New Jersey
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.